Literature DB >> 103475

Solitary plasmacytoma of the larynx and upper trachea associated with systemic lupus erythematosus.

S R Cohen, B H Landing, H Isaacs, K K King, V Hanson.   

Abstract

Solitary plasmacytoma rarely involves the larynx and trachea. This tumor caused severe laryngeal and tracheal obstruction in an adolescent female with systemic lupus erythematosus of nine years' duration. Her systemic disease had been in remission at the time she developed symptoms of laryngeal and tracheal obstruction by plasmacytoma invasion. A complete survey failed to reveal any other focus of tumor. Because steroid therapy failed to clear the plasma cell infiltrate, she was treated with irradiation after the tumor was surgically debulked endoscopically. Postirradiation biopsy showed no evidence of tumor, but the patient continued to experience moderate airway obstruction from fibrosis in the irradiated trachea. The patient has been followed, and is free of disease nine years after establishing the diagnosis.

Entities:  

Mesh:

Year:  1978        PMID: 103475     DOI: 10.1177/00034894780870s503

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  3 in total

1.  Solitary plasmacytoma of the trachea treated by loop resection and laser therapy.

Authors:  R A Kairalla; C R Carvalho; A A Parada; V A Alves; P H Saldiva
Journal:  Thorax       Date:  1988-12       Impact factor: 9.139

2.  Anaplastic myeloma in systemic lupus erythematosus.

Authors:  R C Butler; S M Thomas; J M Thompson; A C Keat
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

3.  Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review.

Authors:  Elżbieta Szczepanek; Joanna Drozd-Sokołowska; Jacek Sokołowski; Anna Rzepakowska; Arkadiusz Moskwa; Jakub Pachla; Jakub Grzybowski; Katarzyna Woźnica; Kazimierz Niemczyk; Krzysztof Jamroziak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.